Synthesis and characterization of magnesium gluconate contained poly(lactic-co-glycolic acid)/chitosan microspheres
Source abstract
Abstract
Abstract The goal of this study was to fabricate and investigate the chitosan coated poly(lactic- co -glycolic acid) (PLGA) microspheres for the development of controlled release magnesium delivery system. PLGA based microspheres are ideal vehicles for many controlled release drug delivery applications. Chitosan is a naturally occurring biodegradable and biocompatible polysaccharide, which can coat the surface of PLGA to alter the release of drugs. Magnesium gluconate (MgG) was encapsulated in the PLGA and PLGA/chitosan microspheres by utilizing the double emulsion solvent evaporation technique for controlled release study. The microspheres were tested with respect to several physicochemical and biological properties, including morphology, chemical structure, chitosan adsorption efficiency, magnesium encapsulation efficiency, in vitro release of magnesium ions, and cellular compatibility using both human adipose-derived stem cells (ASCs) and PC12 cells. Chitosan coated PLGA microspheres can significantly control the release of magnesium ions compared to uncoated PLGA microspheres. Both coated and uncoated microspheres showed good cellular compatibility.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Magnesium in Health and Disease · Layered Double Hydroxides Synthesis and Applications · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Magnesium metabolism and its disorders
2. Hypomagnesemia and mortality in incident hemodialysis patients10.1053/j.ajkd.2015.05.024 ↗
3. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis10.1038/ki.2013.327 ↗
4. Magnesium: An update on physiological, clinical and analytical aspects10.1016/S0009-8981(99)00258-2 ↗
5. Suboptimal magnesium status in the United States: are the health consequences underestimated?10.1111/j.1753-4887.2011.00465.x ↗
6. Hypomagnesemia and hypokalemia: a successful oral therapeutic approach after 16 years of potassium and magnesium intravenous replacement therapy10.1093/ckj/sfu014 ↗
7. Assessment of magnesium status for diagnosis and therapy
8. Magnesium deficiency: pathophysiologic and clinical overview10.1016/S0272-6386(12)80667-6 ↗
9. Hypomagnesemia10.1681/ASN.V1071616 ↗
10. Clinical consequences and management of hypomagnesemia10.1681/ASN.2007111194 ↗
11. Magnesium and its alloys as orthopedic biomaterials: a review10.1016/j.biomaterials.2005.10.003 ↗
12. Magnesium metabolism10.5049/EBP.2008.6.2.86 ↗
13. Biodegradable nanoparticles for drug and gene delivery to cells and tissue10.1016/S0169-409X(02)00228-4 ↗
14. Environment-sensitive hydrogels for drug delivery10.1016/S0169-409X(01)00203-4 ↗
15. Microspheres for controlled release drug delivery10.1517/14712598.4.1.35 ↗
16. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier10.3390/polym3031377 ↗
17. PEGylated nanoparticles for biological and pharmaceutical applications10.1016/S0169-409X(02)00226-0 ↗
18. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery10.1021/mp2005615 ↗
19. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review10.1016/S0142-9612(00)00126-5 ↗
20. Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach
21. Influence of salt form and concentration on the absorption of magnesium in rat small intestine
22. Use of the ninhydrin assay to measure the release of chitosan from oral solid dosage forms10.1016/j.ijpharm.2003.11.023 ↗
23. Regional anatomic and age effects on cell function of human adipose-derived stem cells10.1097/SAP.0b013e3181723bbe ↗
24. Effect of hydrophilic and hydrophobic polymers on release kinetics of metoprolol succinate extended release tablets10.4103/0973-8398.84550 ↗
25. In vitro evaluation of the effect of combination of hydrophilic and hydrophobic polymers on controlled release zidovudine matrix tablets10.4103/0250-474X.44594 ↗
26. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine10.1016/j.jconrel.2008.09.006 ↗
27. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery10.1007/s11095-010-0103-0 ↗
28. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery10.1208/s12249-013-9943-3 ↗
29. Magnesium deficiency results in an increased formation of osteoclasts10.1016/j.jnutbio.2012.12.008 ↗
30. Effect of preparative parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres made by the double emulsion method10.1016/0378-5173(96)04639-X ↗